Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (56)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Leonard, R. C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leonard, R. C. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 2:655-662, 1991
© 1991 European Society for Medical Oncology

research-article

Original article: The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma

R. C. F. Leonard1, R. L. Hayward2, R. J. Prescott3, J.-X. Wang3 and with members of the Scotland and Newcastle Lymphoma Group Therapy Working Party: N. C. Allan, A. Barrett, S. N. Das, A. A. Dawson, A. Heppleston, A. M. Lessells, N. P. Lucie, H. H. Lucraft, M. J.Mackie, K. S. MacLaren, A. C. Parker, S. J. Proctor, T. K. Sarkar, T. Sheehan, M. Soukop, W. P. Steward, J. M. White

1Department of Clinical Oncology, Western General Hospital Edinburgh, UK
2Medical Student, University of Edinburgh Edinburgh, UK
3Medical Statistics Unit, Department of Community Medicine, University of Edinburgh Medical School Edinburgh, UK

Correspondence to: Dr. RCF Leonard, Department of Clinical Oncology, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK

A prognostic model was developed by examination of the prospectively recorded presentation characteristics of patients presenting with low grade non-Hodgkin's lymphomas (LGL). A geographically distinct group (Edinburgh and Borders) was excluded in order to rest the validity of the model based on the rest of the Scotland and Newcastle Lymphoma Group (SNLG) population. Between 1979 and 1987 506 patients presented with low grade lymphoma according to Working Formulation definition with in one of each of the three main pathology categories [1]. The median available follow-up was 47 months. In a multivariate analysis performance status, age, stage, gender and haemoglobin all contributed separately. 25% of all patients had relatively good prognosis with a median survival not reached and 84% alive at 5 years. Conversely for the worst prognostic group of 25% of patients the median survival is 18 months with only 26% surviving at 5 years. Finally for the intermediate group of 50% of all patients, median survival is 69 months with 58% alive at 5 years. These striking prognostic separations are shown also to be valid in sub-group analysis. Thus young patients within any pathology subgroup have been identified with bad prognostic lymphoma for whom novel strategies in therapy should be devised.

prognosis, low grade non-Hodgkin's lymphoma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCOHome page
M. Federico, M. Bellei, L. Marcheselli, S. Luminari, A. Lopez-Guillermo, U. Vitolo, B. Pro, S. Pileri, A. Pulsoni, P. Soubeyran, et al.
Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
J. Clin. Oncol., September 20, 2009; 27(27): 4555 - 4562.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
G. Perea, A. Altes, S. Montoto, A. Lopez-Guillermo, E. Domingo-Domenech, A. Fernandez-Sevilla, J. M. Ribera, J. Grau, C. Pedro, J. Angel Hernandez, et al.
Prognostic indexes in follicular lymphoma: a comparison of different prognostic systems
Ann. Onc., September 1, 2005; 16(9): 1508 - 1513.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. Montoto, A. Lopez-Guillermo, A. Altes, G. Perea, A. Ferrer, M. Camos, L. Villela, F. Bosch, J. Esteve, F. Cervantes, et al.
Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression
Ann. Onc., October 1, 2004; 15(10): 1484 - 1489.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Solal-Celigny, P. Roy, P. Colombat, J. White, J. O. Armitage, R. Arranz-Saez, W. Y. Au, M. Bellei, P. Brice, D. Caballero, et al.
Follicular Lymphoma International Prognostic Index
Blood, September 1, 2004; 104(5): 1258 - 1265.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. Montoto, A. Lopez-Guillermo, A. Ferrer, M. Camos, A. Alvarez-Larran, F. Bosch, J. Blade, F. Cervantes, J. Esteve, F. Cobo, et al.
Survival after progression in patients with follicular lymphoma: analysis of prognostic factors
Ann. Onc., April 1, 2002; 13(4): 523 - 530.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Federico, U. Vitolo, P. L. Zinzani, T. Chisesi, V. Clo, G. Bellesi, M. Magagnoli, M. Liberati, C. Boccomini, P. Niscola, et al.
Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases
Blood, February 1, 2000; 95(3): 783 - 789.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. Decaudin, E. Lepage, N. Brousse, P. Brice, J.-L. Harousseau, K. Belhadj, H. Tilly, L. Michaux, S. Cheze, B. Coiffier, et al.
Low-Grade Stage III-IV Follicular Lymphoma: Multivariate Analysis of Prognostic Factors in 484 Patients--A Study of the Groupe d'Etude des Lymphomes de l'Adulte
J. Clin. Oncol., August 1, 1999; 17(8): 2499 - 2499.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
P J Mounter and A L Lennard
Classic diseases revisited: Management of non-Hodgkin's lymphomas
Postgrad. Med. J., January 1, 1999; 75(879): 2 - 6.
[Abstract] [Full Text]

Home page
 NEJMHome page
P. Solal-Celigny, E. Lepage, N. Brousse, F. Reyes, C. Haioun, M. Leporrier, M. Peuchmaur, A. Bosly, Y. Parlier, P. Brice, et al.
Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular Lymphoma
N. Engl. J. Med., November 25, 1993; 329(22): 1608 - 1614.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.